249 related articles for article (PubMed ID: 33205959)
1. Comparison of Elemental Anomalies Following Implantation of Different Cell Lines of Glioblastoma Multiforme in the Rat Brain: A Total Reflection X-ray Fluorescence Spectroscopy Study.
Planeta K; Setkowicz Z; Janik-Olchawa N; Matusiak K; Ryszawy D; Drozdz A; Janeczko K; Ostachowicz B; Chwiej J
ACS Chem Neurosci; 2020 Dec; 11(24):4447-4459. PubMed ID: 33205959
[TBL] [Abstract][Full Text] [Related]
2. Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.
Planeta K; Setkowicz Z; Czyzycki M; Janik-Olchawa N; Ryszawy D; Janeczko K; Simon R; Baumbach T; Chwiej J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054889
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma multiforme influence on the elemental homeostasis of the distant organs: the results of inter-comparison study carried out with TXRF method.
Wilk A; Setkowicz Z; Banas D; Fernández-Ruiz R; Marguí E; Matusiak K; Wrobel P; Wudarczyk-Mocko J; Janik-Olchawa N; Chwiej J
Sci Rep; 2024 Jan; 14(1):1254. PubMed ID: 38218977
[TBL] [Abstract][Full Text] [Related]
4. Vibrational spectroscopy methods for investigation of the animal models of glioblastoma multiforme.
Olbrich K; Setkowicz Z; Kawon K; Czyzycki M; Janik-Olchawa N; Carlomagno I; Aquilanti G; Chwiej J
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Dec; 303():123230. PubMed ID: 37586277
[TBL] [Abstract][Full Text] [Related]
5. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
6. Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.
Kavitha CV; Jain AK; Agarwal C; Pierce A; Keating A; Huber KM; Serkova NJ; Wempe MF; Agarwal R; Deep G
Mol Carcinog; 2015 Nov; 54(11):1417-29. PubMed ID: 25252179
[TBL] [Abstract][Full Text] [Related]
7. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
[TBL] [Abstract][Full Text] [Related]
8. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
10. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
Yamada T; Tsuji S; Nakamura S; Egashira Y; Shimazawa M; Nakayama N; Yano H; Iwama T; Hara H
J Neurosurg; 2020 Mar; 134(3):701-710. PubMed ID: 32168477
[TBL] [Abstract][Full Text] [Related]
11. Live-Cell Synchrotron-Based FTIR Evaluation of Metabolic Compounds in Brain Glioblastoma Cell Lines after Riluzole Treatment.
Dučić T; Ninkovic M; Martínez-Rovira I; Sperling S; Rohde V; Dimitrijević D; Jover Mañas GV; Vaccari L; Birarda G; Yousef I
Anal Chem; 2022 Feb; 94(4):1932-1940. PubMed ID: 34965097
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide.
Feng SW; Wu ZS; Chiu YL; Huang SM
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298208
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
14. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
15. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
[TBL] [Abstract][Full Text] [Related]
16. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
[TBL] [Abstract][Full Text] [Related]
17. Isofuranodiene synergizes with temozolomide in inducing glioma cells death.
Brunetti A; Marinelli O; Morelli MB; Iannarelli R; Amantini C; Russotti D; Santoni G; Maggi F; Nabissi M
Phytomedicine; 2019 Jan; 52():51-59. PubMed ID: 30599912
[TBL] [Abstract][Full Text] [Related]
18. Natural substances to potentiate canonical glioblastoma chemotherapy.
Arcella A; Sanchez M
J Chemother; 2021 Sep; 33(5):276-287. PubMed ID: 33468026
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.
Cheng ZX; Yin WB; Wang ZY
Int J Mol Med; 2017 Nov; 40(5):1307-1314. PubMed ID: 28901390
[TBL] [Abstract][Full Text] [Related]
20. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.
St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P
J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
